Trivet Pharmaceuticals Private Limited
About Trivet Pharmaceuticals Private Limited
Data last updated:
Trivet Pharmaceuticals Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24232HR2005PTC035709. Its GSTIN is 06AACCT5124B1ZW (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Saroj Bansal and Ajay Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at K – 105 Palm Residency Sector – 35 Karnal – 132001, Haryana, India – 132001.
As per the financials filed for FY 2024, the company reported a revenue of ₹94.96 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹22,574 (net margin 0.2%) and EBITDA of ₹72,402 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Trivet Pharmaceuticals Private Limited's registered office is in Karnal, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressK – 105 Palm Residency Sector – 35 Karnal – 132001, Haryana, India – 132001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Trivet Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Trivet Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Trivet Pharmaceuticals Private Limited, buy the company report.
Financials of Trivet Pharmaceuticals Private Limited
FY 2025 filings availableTrivet Pharmaceuticals Private Limited reported revenue of ₹94.96 Lakh (down 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹72,402 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22,574 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trivet Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trivet Pharmaceuticals Private Limited
Trivet Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saroj Bansal | Director | 26 Nov 2015 | 10 Years 11 Months | Current |
| Ajay Bansal | Director | 27 Apr 2005 | 21 Years 5 Months | Current |
| Rohan Bansal Also directs: Auxbuild Infra LLP | Director | 17 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Trivet Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zentum Pharmaceuticals Private Limited | ₹95.1 Lakh (FY 2024) | -7.0% | Chennai, Tamil Nadu, India | |||
| Trivet Pharmaceuticals Private Limitedthis company | ₹94.96 Lakh (FY 2024) | ₹22,574 | 0.2% | -7.0% | Karnal, Haryana, India | |
| Orbit Chem Pharmaceuticals Private Limited | ₹94.95 Lakh (FY 2024) | -51.0% | Cherapalli, Telangana, India | |||
| NBM Pharmaceuticals Private Limited | ₹94.22 Lakh (FY 2025) | 37.0% | Jodhpur, Rajasthan, India |
To see the full peer comparison of Trivet Pharmaceuticals Private Limited, buy the company report.
Auditor
Trivet Pharmaceuticals Private Limited is audited by ANEJA KAMBOJ & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANEJA KAMBOJ & CO | FY 2022 | 013748N |
Shareholding
The shareholding of Trivet Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Trivet Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Trivet Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trivet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Trivet Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCT5124B1ZW | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Trivet Pharmaceuticals Private Limited, buy the company report.
Recent activity
Trivet Pharmaceuticals Private Limited has 7 board changes on record since 2005: 3 appointments and 4 cessations. The latest: Rohan Bansal was appointed as Director on 17 Nov 2025.
Frequently asked questions
Trivet Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 April 2005 (21+ years old) and is registered under CIN U24232HR2005PTC035709.
Trivet Pharmaceuticals has 3 current directors:
- Saroj Bansal - Director
- Ajay Bansal - Director
- Rohan Bansal - Director
The latest financial statements of Trivet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Trivet Pharmaceuticals is 06AACCT5124B1ZW, registered in Haryana.
The CIN (Corporate Identification Number) of Trivet Pharmaceuticals is U24232HR2005PTC035709. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trivet Pharmaceuticals was incorporated on 27 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Trivet Pharmaceuticals by revenue are Zentum Pharmaceuticals Private Limited, Orbit Chem Pharmaceuticals Private Limited, NBM Pharmaceuticals Private Limited, all in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (retail trading).
Rohan Bansal was appointed as Director on 17 Nov 2025. Saroj Bansal ceased to be Additional Director on 28 Sep 2016. Anurag Goel ceased to be Director on 26 Nov 2015. Trivet Pharmaceuticals has 7 board changes on record in total.
The registered office of Trivet Pharmaceuticals is at K – 105 Palm Residency Sector – 35 Karnal – 132001, Haryana, India – 132001.
Trivet Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Trivet Pharmaceuticals is compliant as of 06 July 2026. The company is actively filing with the Registrar of Companies.